Literature DB >> 36241870

Brief overview of dietary intake, some types of gut microbiota, metabolic markers and research opportunities in sample of Egyptian women.

Nayera E Hassan1, Salwa M El Shebini2, Sahar A El-Masry3, Nihad H Ahmed2, Ayat N Kamal1, Ahmed S Ismail1, Khadija M Alian1, Mohammed I Mostafa4, Mohamed Selim5, Mahmoud A S Afify1.   

Abstract

Metabolic syndrome (MetS) is a phenotype caused by the interaction of host intrinsic factors such as genetics and gut microbiome, and extrinsic factors such as diet and lifestyle. To demonstrate the interplay of intestinal microbiota with obesity, MetS markers, and some dietary ingredients among samples of Egyptian women. This study was a cross-sectional one that included 115 Egyptian women; 82 were obese (59 without MetS and 23 with MetS) and 33 were normal weight. All participants were subjected to anthropometric assessment, 24 h dietary recall, laboratory evaluation of liver enzymes (AST and ALT), leptin, short chain fatty acids (SCFA), C-reactive protein, fasting blood glucose, insulin, and lipid profile, in addition to fecal microbiota analysis for Lactobacillus, Bifidobacteria, Firmicutes, and Bacteroid. Data showed that the obese women with MetS had the highest significant values of the anthropometric and the biochemical parameters. Obese MetS women consumed a diet high in calories, protein, fat, and carbohydrate, and low in fiber and micronutrients. The Bacteroidetes and Firmicutes were the abundant bacteria among the different gut microbiota, with low Firmicutes/Bacteroidetes ratio, and insignificant differences between the obese with and without MetS and normal weight women were reported. Firmicutes/Bacteroidetes ratio significantly correlated positively with total cholesterol and LDL-C and negatively with SCFA among obese women with MetS. Findings of this study revealed that dietary factors, dysbiosis, and the metabolic product short chain fatty acids have been implicated in causing metabolic defects.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36241870     DOI: 10.1038/s41598-022-21056-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  35 in total

Review 1.  Short chain fatty acids in human gut and metabolic health.

Authors:  E E Blaak; E E Canfora; S Theis; G Frost; A K Groen; G Mithieux; A Nauta; K Scott; B Stahl; J van Harsselaar; R van Tol; E E Vaughan; K Verbeke
Journal:  Benef Microbes       Date:  2020-08-31       Impact factor: 4.205

2.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

Review 3.  Gut microbiota-derived metabolites as central regulators in metabolic disorders.

Authors:  Allison Agus; Karine Clément; Harry Sokol
Journal:  Gut       Date:  2020-12-03       Impact factor: 23.059

Review 4.  Gut microbiota functions: metabolism of nutrients and other food components.

Authors:  Ian Rowland; Glenn Gibson; Almut Heinken; Karen Scott; Jonathan Swann; Ines Thiele; Kieran Tuohy
Journal:  Eur J Nutr       Date:  2017-04-09       Impact factor: 5.614

Review 5.  Interaction between microbiota and immunity in health and disease.

Authors:  Danping Zheng; Timur Liwinski; Eran Elinav
Journal:  Cell Res       Date:  2020-05-20       Impact factor: 25.617

6.  Revised Estimates for the Number of Human and Bacteria Cells in the Body.

Authors:  Ron Sender; Shai Fuchs; Ron Milo
Journal:  PLoS Biol       Date:  2016-08-19       Impact factor: 8.029

Review 7.  Introduction to the human gut microbiota.

Authors:  Elizabeth Thursby; Nathalie Juge
Journal:  Biochem J       Date:  2017-05-16       Impact factor: 3.857

Review 8.  The Global Epidemic of the Metabolic Syndrome.

Authors:  Mohammad G Saklayen
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

9.  Gut microbiota and metabolic health among overweight and obese individuals.

Authors:  Mi-Hyun Kim; Kyung Eun Yun; Jimin Kim; Eunkyo Park; Yoosoo Chang; Seungho Ryu; Hyung-Lae Kim; Han-Na Kim
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.